Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

predictor

  • You have access
    Survival Outcome for Peptide Receptor Radionuclide Therapy in Olfactory Neuroblastoma
    HIDENORI SUZUKI, HIROYA TANIGUCHI, YOSHITAKA INABA, HIROYUKI TACHIBANA, SHINTARO BEPPU, HOSHINO TERADA, YOSHIAKI KOBAYASHI and NOBUHIRO HANAI
    Anticancer Research September 2025, 45 (9) 3877-3884; DOI: https://doi.org/10.21873/anticanres.17746
  • You have access
    Metabolic Tumor Volume as Significant Predictor for Chemotherapy Containing PD-L1 Blocker in Extensive Stage Small Cell Lung Cancer
    KOSUKE HASHIMOTO, KYOICHI KAIRA, HISAO IMAI, YU MIURA, AYAKO SHIONO, ATSUTO MOURI, OU YAMAGUCHI, KUNIHIKO KOBAYASHI, HIROSHI KAGAMU and ICHIEI KUJI
    Anticancer Research April 2024, 44 (4) 1541-1551; DOI: https://doi.org/10.21873/anticanres.16951
  • You have access
    Association of High Neutrophil-to-Lymphocyte Ratio With Poor Outcomes of Pembrolizumab Therapy in High-PD-L1-expressing Non-small Cell Lung Cancer
    TSUKASA HASEGAWA, NORIKO YANAGITANI, HIROFUMI UTSUMI, HIROSHI WAKUI, HIROAKI SAKAMOTO, TAKEHIRO TOZUKA, HIROSHI YOSHIDA, YOSHIAKI AMINO, SHINYA UEMATSU, TAKAHIRO YOSHIZAWA, KEN UCHIBORI, SATORU KITAZONO, ATSUSHI HORIIKE, TAKESHI HORAI, KAZUYOSHI KUWANO and MAKOTO NISHIO
    Anticancer Research December 2019, 39 (12) 6851-6857; DOI: https://doi.org/10.21873/anticanres.13902
  • You have access
    Primary Tumor Size Predicts Distant Metastasis of Mucosal Malignant Melanoma in Head and Neck
    HIDENORI SUZUKI, GAKU TAKANO, NOBUHIRO HANAI, DAISUKE NISHIKAWA, YUSUKE KOIDE, SHINTARO BEPPU and YASUHISA HASEGAWA
    Anticancer Research November 2018, 38 (11) 6485-6490; DOI: https://doi.org/10.21873/anticanres.13012
  • You have access
    Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer
    FUMIHIRO SHOJI, TAICHI MATSUBARA, YUKA KOZUMA, NAOKI HARATAKE, TAKAKI AKAMINE, SHINKICHI TAKAMORI, MASAKAZU KATSURA, GOUJI TOYOKAWA, TATSURO OKAMOTO and YOSHIHIKO MAEHARA
    Anticancer Research December 2017, 37 (12) 6997-7003;
  • You have access
    L-[3-18F]-α-Methyltyrosine Accumulation as a Definitive Chemoradiotherapy Response Predictor in Patients with Esophageal Cancer
    MAKOTO SOHDA, HIROAKI HONJYO, KEIGO HARA, DAIGO OZAWA, SHIGEMASA SUZUKI, NARITAKA TANAKA, AKIHIKO SANO, MAKOTO SAKAI, TAKEHIKO YOKOBORI, TAKANORI INOSE, TATSUYA MIYAZAKI, HITOSHI OJIMA, TETSUYA HIGUCHI, YOSHITO TSUSHIMA and HIROYUKI KUWANO
    Anticancer Research February 2014, 34 (2) 909-913;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire